Skip to main content

Table 1 Patient demographics and baseline clinical characteristics

From: Efficacy of intravenous tranexamic acid administration in medial opening-wedge distal tibial tuberosity osteotomy (MOWDTO) for varus knee osteoarthritis: a randomized control trial

 

TXA group

(n = 31 knees)

Control group

(n = 30 knees)

P-value

Age (years)

57.4 ± 8.7

58.0 ± 8.6

0.805

Sex (female/male)

15/16

16/14

0.800

Height (cm)

161 ± 8.8

164 ± 6.5

0.139

Weight (kg)

67.7 ± 17.3

70.6 ± 16.2

0.499

BMI (kg/m2)

25.8 ± 4.9

26.1 ± 5.0

0.855

Preoperative Hb (g/dl)

14.2 ± 1.3

14.2 ± 1.3

0.884

Preoperative Ht (%)

41.7 ± 3.7

42.0 ± 3.0

0.743

Preoperative D-dimer (mg/dl)

0.5 ± 0.4

0.4 ± 0.1

0.294

Preoperative lower leg circumference

37.4 ± 3.6

36.3 ± 3.3

0.354

Preoperative VAS at rest

11.0 ± 16.6

16.1 ± 24.0

0.378

Duration of surgery (min)

Medial opening gap width (mm)

84.1 ± 16.8

8.9 ± 3.4

83.7 ± 23.2

8.4 ± 2.5

0.934

0.537

  1. Results are expressed as means ± standard deviation
  2. TXA tranexamic acid, BMI body mass index, Hb hemoglobin, VAS visual analogue scale